The Urokinase-Type Plasminogen Activator Receptor (uPAR) as a Mediator of Physiological and Pathological Processes: Potential Therapeutic Strategies. [PDF]
Iftikhar A, Mahmood N, Rabbani SA.
europepmc +1 more source
The activation of pro-urokinase by plasma kallikrein and its inactivation by thrombin.
Akitada Ichinose +2 more
openalex +1 more source
Research Priorities for Malignant Pleural Organization with Loculation and Failed Drainage. [PDF]
Tucker TA +3 more
europepmc +1 more source
Combination of prostate cancer antigen 3 (PCA3), sarcosine, glypican-1 (GPC1), urokinase plasminogen activator receptor (uPAR), and thymidine kinase 1 (TK1), and T2WI and DWI radiomics model for distinguishing benign prostatic hyperplasia, prostate cancer, and prostatitis. [PDF]
Yang F, Guo W, Sun S, Huang Y.
europepmc +1 more source
Predictive enrichment using biomarkers in studies of critically-ill patients with sepsis: a systematic review. [PDF]
Van Nynatten LR +12 more
europepmc +1 more source
Identifying new blood biomarkers of neuroplasticity associated with rehabilitation outcomes after stroke. [PDF]
Garcia-Rodriguez N +19 more
europepmc +1 more source
Soluble Urokinase Plasminogen Activator Receptor Predicts Survival and Hepatic Decompensation in Advanced Hepatocellular Carcinoma. [PDF]
Artusa F +17 more
europepmc +1 more source
uPAR and cFn as candidate protein biomarkers for identifying low response to rtPA in acute ischemic stroke. [PDF]
Wang Y +11 more
europepmc +1 more source
Management of vision loss associated with complications of cosmetic filler injections. [PDF]
Madala S +6 more
europepmc +1 more source
Soluble urokinase plasminogen activator receptor promotes endoplasmic reticulum stress and apoptosis susceptibility through RAGE in sepsis acute kidney injury. [PDF]
Wang B +11 more
europepmc +1 more source

